Stocktoria
LEXICON PHARMACEUTICALS, INC. LXRX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2000-04-07
LEXICON PHARMACEUTICALS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -98.2% | -634.2% | -14265.0% | -72489.2% | -29224.8% |
| Net margin | -101.1% | -644.8% | -14710.9% | -73341.0% | -29449.0% |
| FCF margin | -136.2% | -578.5% | -13485.6% | -64875.5% | -29610.1% |
| Return on assets | -27.2% | -67.2% | -77.2% | -52.5% | -64.1% |
| Return on equity | -46.8% | -137.3% | -190.2% | -87.0% | -77.3% |
| Debt / equity | 0.46× | 0.69× | 1.07× | 0.41× | 0.00× |
| Current ratio | 4.88 | 5.44 | 5.60 | 6.08 | 4.02 |
| Revenue growth | 60.2% | 2481.5% | 766.2% | -53.4% | -98.8% |
Source: SEC EDGAR filings · CIK 0001062822 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.